Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole

被引:21
|
作者
Bennett, MT
Sirrs, S
Yeung, JK
Smith, CA
机构
[1] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[2] Univ British Columbia, Div Endocrinol, Vancouver, BC, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[4] Univ British Columbia, Div Hematol, Vancouver, BC, Canada
关键词
hypercalcemia; ATRA; all-trans-retinoic acid; APL; acute promyelocytic leukemia; voriconazole;
D O I
10.1080/10428190500235298
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
All-trans-retinoic acid ( ATRA) is a new and effective treatment of acute promyelocytic leukemia. It has many side-effects, including the retinoic acid syndrome and Sweet's syndrome. There have been only nine cases of hypercalcemia associated with ATRA described in the literature. We discuss a case of hypercalcemia, which we believe was due to inhibition of cytochrome P450 function by voriconizole when used concomitantly with ATRA.
引用
收藏
页码:1829 / 1831
页数:3
相关论文
共 50 条
  • [21] All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia
    Masetti, Riccardo
    Vendemini, Francesca
    Zama, Daniele
    Biagi, Carlotta
    Gasperini, Pietro
    Pession, Andrea
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1191 - 1204
  • [22] ALL-TRANS-RETINOIC ACID (ATRA) AS A TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    GOMEZFUENTES, GH
    LABARDINIMENDEZ, J
    HURTADOMONROY, R
    VELAZQUEZGONZALEZ, A
    MIJANGOSHUESCA, FJ
    LOARCAPINA, LM
    BLOOD, 1994, 84 (10) : A619 - A619
  • [23] All-trans retinoic acid:: Treatment and toxicity in acute promyelocytic leukemia
    Ayyildiz, O
    Aybak, M
    Tiftik, N
    Müftüoglu, E
    12TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 2000, : 149 - 153
  • [24] All-trans retinoic acid - Progress in treatment of acute promyelocytic leukemia
    Lengfelder, E
    Hehlmann, R
    ONKOLOGIE, 1997, 20 (02): : 122 - 124
  • [25] All-trans-retinoic acid in acute promyelocytic leukemia
    Tallman, MS
    Andersen, JW
    Schiffer, CA
    Appelbaum, FR
    Feusner, JH
    Ogden, A
    Shepherd, L
    Willman, C
    Bloomfield, CD
    Rowe, JM
    Wiernik, PH
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15): : 1021 - 1028
  • [26] All-trans-retinoic acid in acute promyelocytic leukemia
    Sanz, MA
    Martín, G
    Díaz-Mediavilla, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (06): : 393 - 393
  • [27] Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case
    Afacan Ozturk, Hacer Berna
    Albayrak, Murat
    Maral, Senem
    Reis Aras, Merih
    Yilmaz, Fatma
    Akyol, Pinar
    Tiglioglu, Mesut
    Malkan, Umit Yavuz
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (08) : 2027 - 2029
  • [28] Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid
    Cordoba, R.
    Ramirez, E.
    Lei, S. H.
    Lopez de la Guia, A.
    Sanjurjo, M. J.
    Carcas, A. J.
    Hernandez-Navarro, F.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (10) : 1031 - 1032
  • [29] Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid
    R. Cordoba
    E. Ramirez
    S. H. Lei
    A. Lopez de la Guia
    M. J. Sanjurjo
    A. J. Carcas
    F. Hernandez-Navarro
    European Journal of Clinical Pharmacology, 2008, 64 : 1031 - 1032
  • [30] ALL-TRANS-RETINOIC ACID AS AN ALTERNATIVE TO CHEMOTHERAPY IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    KUHNE, T
    IMBACH, P
    SIGNER, E
    OSTERWALDER, B
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1993, 10 (04) : 363 - 367